CCA responds to the Royal Pharmaceutical Society – Daffodil Standards for End of Life Care
The CCA responded to the RPS’ consultation on Community Pharmacy Quality Improvement (‘Daffodil’) Standards for Palliative and End of Life...
The CCA responded to the RPS’ consultation on Community Pharmacy Quality Improvement (‘Daffodil’) Standards for Palliative and End of Life...
The CCA responded to the Public Account Committee’s inquiry into managing the NHS backlog. In our response we propose standardising...
The CCA responded to the Health and Social Care Committee’s Expert Panel inquiry on the digitalisation of the NHS. In...
The CCA welcome the changes made by the Health and Care Act 2022 to allow statutory NHS commissioners and providers...
The CCA responded to the RPS and King’s Fund call for evidence into the future of pharmacy.
The CCA submitted written evidence in response to the Scottish Government’s consultation on its Suicide Prevention Strategy. The response reflects...
The CCA responded to DHSC’s consultation on its Mental Health Plan.
We welcome the opportunity to respond to DHSC’s hub and spoke consultation. You can find the CCA’s response by clicking...
The CCA submitted written evidence in response to the Health and Social Care Committee’s inquiry into digital transformation in the...
The CCA submitted written evidence on the Scottish Government’s New Cancer Strategy. Recognition of community pharmacy’s clinical capacity, through better...
The CCA submitted comments to NICE’s draft guidelines on tobacco: preventing uptake, promoting quitting and treating dependence. Our response calls...
The CCA was pleased to respond to the General Pharmaceutical Council’s consultation on its Draft Equality Guidance for Pharmacies. We...